Holen Sie sich die Stockscreener-App
314.84
4.74%
-15.68
Handel nachbörslich:
314.84
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$330.52
Offen:
$326.61
24-Stunden-Volumen:
2.85M
Relative Volume:
1.12
Marktkapitalisierung:
$120.70B
Einnahmen:
$25.27B
Nettoeinkommen (Verlust:
$3.34B
KGV:
36.47
EPS:
8.6334
Netto-Cashflow:
$4.57B
1W Leistung:
+1.56%
1M Leistung:
+3.20%
6M Leistung:
-10.42%
1J Leistung:
-20.42%
1-Tages-Spanne:
$311.19
$327.00
1-Wochen-Bereich:
$311.19
$334.75
52-Wochen-Spanne:
$281.00
$404.14
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
314.84 | 127.55B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
90.74 | 163.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
MDT
Medtronic Plc
|
78.23 | 103.66B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
42.68 | 65.74B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.46 | 52.27B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Leerink Partners | Outperform |
| 2026-02-20 | Eingeleitet | William Blair | Outperform |
| 2026-01-27 | Fortgesetzt | TD Cowen | Hold |
| 2026-01-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
Stryker Corp (SYK) Stock Down 4.7% -- Now Undervalued? GF Score: 92/100 - GuruFocus
Stryker Corp Stock (SYK) Moved Down by 5.31% on Jun 30: Key Drivers Unveiled - TradingKey
Stryker (SYK) Is Up 8.5% After Broad Russell Growth Index Removal Reshapes Its Shareholder Base - Yahoo Finance
Stryker, analyst consensus stays constructive, shares trade near recent highs - AD HOC NEWS
Is Stryker Corporation (SYK) A Good Stock To Buy Now? - Yahoo Finance
Stryker reports index change, shares hold their ground on NYSE - AD HOC NEWS
Stryker Corporation (SYK) launches TPX HD® Power Tool - Insider Monkey
Stryker Corp clears weekly gain, shares extend June rebound - Ad-hoc-news.de
The Sonopet iQ Ultrasonic Aspirator from Stryker Corp.quieter bone cutting in complex neurosurger - Ad-hoc-news.de
Stryker Corp (SYK) Shares Surge 5.2% -- What GF Score of 92 Tells Investors - GuruFocus
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker recasts prior periods after reorganizing to create Ortho Tech, maintains two reportable segments - TradingView
Stryker (SYK) reshapes segments, buys Inari and lifts 2025 EPS - Stock Titan
Stryker Jumps as Investors Reassess Recovery Story and MedTech Outlook - Moomoo
Stryker updates 2026 outlook, shares hold near $316 - Ad-hoc-news.de
Leerink Sees Attractive Risk-Reward in Stryker (SYK) Despite First-Quarter Revenue Miss - Insider Monkey
Stryker Corp (SYK) Institutional Confidence - TradingKey
What Makes Stryker Corp. (SYK) One of the Best Robotics and Automation Stocks - Insider Monkey
Stryker Seeks to Dismiss Class Action Lawsuit in Cyberattack - BankInfoSecurity
AB Concentrated Growth Fund's Stryker Corp(SYK) Holding History - GuruFocus
Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement - Barchart.com
Stryker cautious after BofA and Barclays trim targets, shares stay firm in S&P 500 - Ad-hoc-news.de
Stryker Says Data Breach Suit Built On Speculation - Law360
The Mako Robotic-Arm Assisted Surgery System from Stryker Corpprecise cuts, consistent knee and h - Ad-hoc-news.de
Stryker shows mixed analyst sentiment, shares hold firm in the S&P 500 - Ad-hoc-news.de
Stryker Corp. stock underperforms Monday when compared to competitors - MarketWatch
Stryker slides, BofA trims target on medtech slowdown - Ad-hoc-news.de
BofA Cuts Stryker (SYK) Target; Is a Medtech Slowdown Starting to Show? - Insider Monkey
Why Is S&P 500 Healthcare Watching Stryker’s Robotics Push? - Kalkine Media
Jim Cramer Says Stryker (SYK) and Its Orthopedic Peers Are Facing a Real Tough Run - Yahoo Finance
Stryker Corp. StockLong-term drivers in focus for this medical devices leader - Ad-hoc-news.de
Stryker StockSaturday background on the medtech group - Ad-hoc-news.de
Microcatheter Market Size to Reach USD 1.79 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
SYK News | STRYKER CORP (NYSE:SYK) - ChartMill
Stryker Corp (SYK) Valuation: PE, PB & Fair Value Analysis - TradingKey
Stryker Corp Stock (SYK) Moved Up by 3.03% on Jun 18: What Signal Does It Send? - TradingKey
Jefferies Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $455 - 富途牛牛
Smaller incisions, bigger controlhow Stryker’s OptaBlate BVN spine tool pushes vertebral ablati - Ad-hoc-news.de
Why Stryker’s Mako SmartRobotics system is reshaping knee surgery - Ad-hoc-news.de
Fed. Circ. Affirms No Block On Stryker Spine Device In IP Fight - Law360
Stryker Corp (SYK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Stryker Corp (SYK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stryker Corp (SYK) Shares Fall 3.0% -- What GF Score of 92 Tells Investors - GuruFocus
UNITED BANK's Stryker Corp(SYK) Holding History - GuruFocus
Stryker Corp. stock outperforms competitors despite losses on the day - MarketWatch
CAFC Affirms Denial of Preliminary Injunction for Boston Scientific in Spinal Ablation Patent Dispute Against Stryker - IPWatchdog.com
Stryker Fends Off Boston Scientific Bid to Block Ablation Device - Bloomberg Law News
Stryker Corp (SYK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Stryker Corp. Stock (US8636671013): Valuation Metrics Back in Focus After Recent Move - AD HOC NEWS
Hybrid approach in the operating room, Stryker’s 1688 AIM 4K Platform targets sharper minimally in - AD HOC NEWS
Stryker Corp. Stock (US8636671013): Valuation focus as newsflow stays light - AD HOC NEWS
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):